Gilead Sciences Inc.

In News

Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know - Yahoo Finance

Yahoo Finance - Sep 17, 2026

Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines - Gilead Sciences

Gilead Sciences - Sep 08, 2026

[Press releases] Gilead Sciences provides updates on access to lenacapavir for HIV prevention - European AIDS Treatment Group

European AIDS Treatment Group - Sep 17, 2026

Gilead Sciences stock gains as HIV drug access expands - AD HOC NEWS

AD HOC NEWS - Sep 20, 2026

Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch

MarketWatch - Sep 17, 2026

Gilead, PAHO agree on HIV prevention drug access in Latin America, Caribbean - Reuters

Reuters - Sep 15, 2026

Gilead Accelerates Global Access Planning for Investigational Once-Yearly Lenacapavir for HIV Prevention - biospace.com

biospace.com - Sep 17, 2026

Gilead and PAHO Announce Milestone Partnership to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention Across Latin America and the Caribbean - Business Wire

Business Wire - Sep 15, 2026

Gilead (NASDAQ: GILD) exec sells 3,000 shares in pre-arranged trades - Stock Titan

Stock Titan - Sep 16, 2026

Nykredit A S Invests $140.59 Million in Gilead Sciences, Inc. $GILD - MarketBeat

MarketBeat - Sep 18, 2026

Gilead Sciences Inc's Dividend Analysis - Yahoo Finance

Yahoo Finance - Sep 15, 2026

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens - Gilead Sciences

Gilead Sciences - Aug 27, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment